Asthma Recent News
AstraZeneca's Two Asthma Trials Meet Primary Endpoints
Amgen, AstraZeneca Tout Additional Data From Asthma Trial With Tezepelumab
Amgen - AstraZeneca's Asthma Candidate Under Priority Review With FDA
New Five-Year Data Shows Durable Efficacy Of AstraZeneca's Fasenra For Asthma Treatment
Sanofi-Regeneron Tout New Data For Dupixent From Pediatric Asthma Trial
Sanofi/Regneron's Dupixent Application For Asthma In Children Accepted For FDA Review
Regeneron's Single-Dose REGN1908-1909 Shows Rapid, Durable Benefit In Cat-Allergic Asthma Patients
AstraZeneca/Amgen's Tezepelumab Reduces Asthma Exacerbations, Phase 3 Trial Shows
Sanofi, Regeneron Report Positive Phase 3 Results For Asthma Drug Dupixent's Use In Children
Amid Few Catalysts, Jefferies Downgrades AstraZeneca